TCM
AMPE

Traynor Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Traynor Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-464
Closed -$65K – 221
2022
Q1 		$65K Buy
464
+28
+6% +$4.09K 0.01% 188
2021
Q4 		$74K Buy
436
+17
+4% +$6.34K 0.01% 205
2021
Q3 		$208K Buy
419
+101
+32% +$46.8K 0.03% 172
2021
Q2 		$155K Buy
318
+113
+55% +$60.7K 0.02% 173
2021
Q1 		$103K Sell
205
-168
-45% -$86.6K 0.02% 169
2020
Q4 		$177K Sell
373
-24
-6% -$7.87K 0.03% 146
2020
Q3 		$96K Buy
397
+23
+6% +$5.7K 0.02% 144
2020
Q2 		$71K Buy
374
+47
+14% +$7.82K 0.02% 145
2020
Q1 		$40K Buy
327
+23
+8% +$4.16K 0.01% 127
2019
Q4 		$53K Buy
304
+122
+67% +$15.8K 0.01% 168
2019
Q3 		$27K Buy
182
+20
+12% +$2.67K 0.01% 164
2019
Q2 		$20K Buy
162
+20
+14% +$3.17K 0.01% 172
2019
Q1 		$23K Buy
142
+29
+26% +$4.97K 0.01% 169
2018
Q4 		$16K Buy
113
+47
+71% +$7.21K 0.01% 154
2018
Q3 		$10K Buy
66
+16
+32% +$6.69K ﹤0.01% 192
2018
Q2 		$30K Buy
50
+2
+4% +$1.5K 0.01% 189
2018
Q1 		$49K Buy
+48
New +$40.2K 0.02% 170

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Traynor Capital Management's AMPE Position: Q2 2022 in Review

Traynor Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 464 shares — an estimated $65K sold.

Traynor Capital Management first reported a position in AMPE in Q1 2018 and held it in 17 quarters. The position peaked at $208K in Q3 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Traynor Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Traynor Capital Management sold 464 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $65K.
  • Traynor Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2018 and held it in 17 quarters.
  • Traynor Capital Management's Ampio Pharmaceuticals Inc. position peaked at $208K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Traynor Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.